Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)

China flag China · Delayed Price · Currency is CNY
7.51
+0.20 (2.74%)
Apr 30, 2026, 11:54 AM CST
7.75%
Market Cap 6.06B
Revenue (ttm) 1.46B
Net Income (ttm) 219.28M
Shares Out 829.67M
EPS (ttm) 0.27
PE Ratio 27.30
Forward PE n/a
Dividend 0.08 (1.07%)
Ex-Dividend Date Jun 6, 2025
Volume 14,282,373
Average Volume 23,918,697
Open 7.18
Previous Close 7.31
Day's Range 7.18 - 7.59
52-Week Range 6.72 - 8.45
Beta 0.20
RSI 45.25
Earnings Date Apr 23, 2026

About SHE:002349

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenobarbital, Primidone, Fluorouracil, Phenylbutazone, Flucytosine, Piroxicam, and Propylthiouracil APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. The company was founded in 1957 and is based in Nantong, China. [Read more]

Sector Healthcare
Founded 1957
Employees 1,490
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002349
Full Company Profile

Financial Performance

In 2025, SHE:002349's revenue was 1.46 billion, an increase of 4.13% compared to the previous year's 1.40 billion. Earnings were 219.28 million, an increase of 3.12%.

Financial Statements

News

There is no news available yet.